Indefinite Delivery Contract 75D30123D18241

Award Date 9/26/23
Last Date to Order 9/25/28
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Duke University Office of Research Administration Division was awarded a multiple-award indefinite delivery/indefinite quantity (IDIQ) contract from the Centers for Disease Control and Prevention (CDC) under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) program. The contract has a potential value of $200,000,000 and a period of performance through September 29, 2021. As the prime contractor, Duke University is providing clinical research and...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Emory University for clinical immunization safety assessment services. The contract has a potential value of $86 million and a period of performance from September 2023 through September 2028. No set-aside was used. Under this contract, Emory University has received two cost-no-fee delivery orders to provide clinical immunization safety assessment support to the CDC. The first delivery...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division. With a potential value of $86M and a period of performance through September 2028, this contract will provide clinical immunization safety assessment services to the CDC. A $305K delivery order was also awarded against this contract to Columbia University for services from September 2023...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery indefinite quantity contract to The Johns Hopkins University on September 26, 2023. With a potential value of $86 million and a period of performance through September 2028, this contract provides clinical immunization safety assessment services. Specifically, the 2023 Clinical Immunization Safety Assessment Base IDIQ aims to procure immunization safety research and consultation. A $954,643 delivery order...
The Centers for Disease Control and Prevention awarded Vanderbilt University Medical Center an indefinite delivery contract with a potential value of $86 million to provide Clinical Immunization Safety Assessment base services from September 2023 through September 2028. Under this multiple award contract vehicle, VUMC will support CDC's immunization safety monitoring and vaccine safety research efforts. CDC also issued a $6.6 million delivery order to VUMC for Clinical Immunization Safety...
The Centers for Disease Control and Prevention awarded Boston Medical Center Corporation an indefinite delivery contract with a potential value of $86 million to provide Clinical Immunization Safety Assessment services. The base IDIQ establishes terms and conditions for future delivery orders related to immunization safety assessments to support the Department of Health and Human Services. Two initial cost-no-fee delivery orders totaling $1.9 million have been issued against the IDIQ. The first,...
The Centers for Disease Control and Prevention awarded an indefinite-delivery/indefinite-quantity contract to Children's Hospital Medical Center, doing business as Children's Home Healthcare, to provide Clinical Immunization Safety Assessment base services. The multiple award contract has a potential value of $86 million with a period of performance from September 2023 through September 2028. Two cost-no-fee delivery orders were also awarded for $1.1 million and $900,000 respectively, with...
The Johns Hopkins University has been awarded a single-award indefinite delivery contract (IDC) by the Centers for Disease Control and Prevention (CDC) to provide clinical immunization safety assessments and consultation services. The $86 million contract has a period of performance from 2023 to 2028. Under this contract, Johns Hopkins will deliver task orders to support the CDC's mission of advancing public health through national immunization programs. A $954,643 delivery order details the...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery/indefinite quantity contract under the Safe Healthcare, Epidemiology, and Prevention Research Development Program to Duke University Office of Research Administration Division. With a potential value of $99 million and a period of performance through September 2026, this contract vehicle aims to procure epidemiological, behavioral and social science research and services across several domains including...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Duke University's Office of Research Administration Division as the prime contractor. The $20,000,000 IDC falls under the NIAID Animal Models of Infectious Diseases 2010-2017 multiple-award IDIQ contract vehicle and does not have any set-aside designations. Under this IDC, Duke University will...
  • 75D30123D18241
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Contract (IDC) to Duke University's Office of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) base services. The $86,008,000.12 multiple-award IDC has a period of performance running through September 2028.

Under this IDC, the CDC has issued two cost-no-fee delivery orders to Duke University totaling $3,053,131. The first order, valued at $875,045, covers CISA base services from September 2023 through September 2028. The second order, worth $2,178,086, provides CISA base services from September 2023 through September 2026. All work will be performed in Durham, North Carolina. As the prime contractor, Duke University will leverage its expertise in clinical research and immunization safety assessments to support the CDC's monitoring and evaluation of vaccine safety under this contract.

Generated 6/13/24, 9:06 AM